Propofol Sedation in Diagnostic Upper Gastrointestinal Endoscopy

Christophorus Simadibrata (Abdi Waluyo Hospital, Jakarta)
Benvenuto Axel (Abdi Waluyo Hospital, Jakarta)
Syahrizal Syahrizal (Department of Anesthesiology, Abdi Waluyo Hospital, Jakarta)
Dina Ikawari (Department of Anesthesiology, Abdi Waluyo Hospital, Jakarta)
Paulus Simadibrata (Abdi Waluyo Hospital, Jakarta)
Marcellus Simadibrata (Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia/Dr.Cipto Mangunkusumo General National Hospital, Jakarta)

The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
Vol 21, No 1 (2020): VOLUME 21, NUMBER 1, April 2020

Background: Sedation are commonly used these days in patients that having gastrointestinal endoscopy. Propofol is sedative  agent  that  commonly  used  in  endoscopy procedure.Method: All   patients   who   were   performed   diagnostic   EGD   in   Abdi   Waluyo   Hospital’s Gastrointestinal Endoscopy Unit from January 1st   2017 – 31st   December 2017, included in this study. The amount of Propofol, duration during hypnosis/sedation and adverse effects were all recorded.Results: 170  patients  were  performed  diagnostic  EGD  with  Propofol  sedation,  most  of them were male (87 patients, 51,5%). The median age was 48,78 + 14. The median Body Mass Index  (BMI)  was  24.45.  The median of duration of hynosis (sedation) during EGD was 5 minutes. The median of propofol total dose during EGD was 180 mg. Adverse effects that found during Propofol sedation are muscle twitching(10.6% patients) and pain in area of  injection(80% patients). Conclusion: The duration of propofol hypnosis/sedation during Esophagogastroduodenoscopy examination was 5 minutes. Propofol total dose needed for diagnostic EGD was 180 mg. The common adverse effects of propofol are muscle twitching and pain in area of injection.